“Ask and it will be given to you; seek and you will find; knock and the door will be opened to you. For everyone who asks receives; the one who seeks finds; and to the one who knocks, the door will be opened. Matthew 7:7-8

5 Apr 2017


                   Gennex Laboratories Ltd.

Setup in 1995 with its unit in Bollaram and office in Banjara hills, Hyderabad, Gennex is among the leading 'Vertically Integrated' pharmaceutical companies in India, Gennex Laboratories has robust product portfolio spread over major product areas encompassing Expectorants, Muscle Relaxants, Analgesic and Anti Fungal. The Vision at Gennex is highlyQuality driven with industry best practices in place. ISO 9001:2008 certified,Gennex has a prominent Global presence, own modern infrastructure (plant spread over 2 acres land), strategic alliances, subsidiaries & joint ventures.

Gennex Laboratories is into manufacturing, marketing and exporting of API’s. All major names in Pharmaceutical Industry both in India and abroad enlist our clientele, with majority of the market share located in Latin America, Mid East and Central Asia. This company is A VAB Venture Company.

The Company visualizes a strong global presence for demand of its products viz, Guaifenesin, Methocarbamol, Phenazopyridine Hydrochloride, Metformin, Fluconazole, Ambroxol Hcl.
Gennex has acquired a unit �Deccan Remedies Limited� built-up on a land of about 32 acres near Zaheerabad, about 100 kms from Hyderabad where civil construction is almost completed. The unit is expected to go on stream in a year and targeted for a mix of High Volume, Low Value and Low Volume, High Value Active Pharmaceuticals Ingredients. The facility is also being designed to meet the approval of regulatory bodies such as US (FDA), EDQM & TGA. This will help Gennex Laboratories to enhance its turnover to 20 Million US$ when fully operational.
Falma Laboratories Private Limited a sister concern located in Bangalore, is a formulation unit and has a strong export base in African Countries. Gennex is actively pursuing synergizing the activity of converting Guaifenesin and Metformin to PFI�s (Pharmaceutical Formulation Intermediates) for export, which will boost its sales and presence in these markets.

The company has approval from the State Drug Control Authority to manufacture various Active Pharmaceuticals Ingredients. Presently the Company is engaged in manufacturing the following APIs keeping in view the market demand:
1.    Guaifenesin USP/BP/EP/IP
2.    Methocarbamol USP
3.    Phenazopyridine Hcl USP
4.    Fluconazole EP/USP
5.    Metformin Hcl IP/BP/USP
6.    Ambroxol Hcl IP/BP
7.    Melitracen Hcl
Therapeutic Category
·         Expectorant, (Mucolyte).
·         Relaxant (skeletal muscle relaxant)
·         Urinary tract analgesic
·         Anti-Fungal
·         Anti-Diabetic
·         Expectorant, (Mucolyte)
·         Antidepressant and Anxiolytic
Guaifenesin,This drug is used as a mucolyte. The respiratory conditions such as bronchitis, bronchial, asthma, emphysema, bronchospasm, bronchiectasis results in �increasing the viscosity of the mucus". This drug reduces the viscosity and increases the secretions of the respiratory tract and used in most of the cough expectorant in combination with other drugs.
Methocarbamol, This is a non-narcotic, non-toxic drug and is preferred in treating conditions like spasm and pain associated with acute musculoskeletal disorders, tension, myalgia, acute traumatic muscle spasm, acute disc prolapse, painful shoulder syndrome etc.
Phenazopyridine Hydrochloride, This drug has a specific local analgesic effect in the urinary tract, promptly relieving burning & pain and gives symptomatic relief of dysuria
Fluconazole, This drug is a bis-triazole anti fungal and widely used for treatment of fungal infections. Used in oral preparations, infections and as a cream
Metformin Hcl, This drug is non-insulin anti-diabetic. Since diabetes is growing in epidemic proportion in Asian Markets, the growth potential for this product in domestic and export is quite enormous.
Ambroxol Hcl This drug is a secretolytic agent used in the treatment of respiratory diseases associated with viscid or excessive mucus.
Melitracen Hydrochloride � Melitracen Hydrochloride is a tricyclic antidepressant with actions and effects similar to amitriptyline. Melitracen Hydrochloride is given orally in the treatment of depression. It should be withdrawn gradually to reduce the risk of withdrawal symptoms.

This is a micro tip stock with a good future. Long term investors can look into it. Share price is Rs. 5/70(BSE/531739).

No comments:

Post a Comment